Guangzhi Wang

Dr. Guangzhi Wang

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Experimental Cell Research
Verified
Journal Article
Closed access
JJJiang Jiang
Jiang Jiang
GWGuangzhi Wang
Guangzhi Wang
YWYing Wang
Ying Wang
HHHao-Zhe Huang
Hao-Zhe Huang
WLWen-Tao Li
Wen-Tao Li
XQXu-Dong Qu
Xu-Dong Qu

1 July 2014 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
ZFZhu-Ting Fang
Zhu-Ting Fang
JWJian-Hua Wang
Jian-Hua Wang
WZWei Zhang
Wei Zhang
GWGuangzhi Wang
Guangzhi Wang
GYGuo-Wei Yang
Guo-Wei Yang
LLLing-Xiao Liu
Ling-Xiao Liu
The aims of this study were to assess the effect of transarterial chemoembolization (TACE) on circulating tumor cells (CTCs) in the peripheral blood and right atrium of patients with HCC and to evaluate whether perioperative shedding of CTCs affects time to progression of HCC. Before and after TACE, peripheral and right atrial blood samples (7.5 mL) were collected from 42 patients with HCC. CTCs were enriched using EpCAM antibody-conjugated magnetic beads. The number of CTCs was 0–30 and 0–54 in peripheral blood before and after TACE, respectively (P=0.166), and 0–65 and 0–98 in the right atrium before and after TACE, respectively (P=0.102). The number of CTCs was significantly different between the two samples both before (P=0.007) and after (P=0.021) TACE. There was no difference in time to progression between patients with and without an increase in the number of CTCs after TACE in either sample (P>0.05 for both). There were more CTCs in right atrial blood than in peripheral blood. The numbers of CTCs in both samples remained unchanged after TACE. Shedding of tumor cells did not affect time to progression of disease in patients with HCC.

1 October 2016 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ZSZeng-Mei Si
Zeng-Mei Si
GWGuangzhi Wang
Guangzhi Wang
SQSheng Qian
Sheng Qian
XQXu-Dong Qu
Xu-Dong Qu
ZYZhi-Ping Yan
Zhi-Ping Yan
JWJian-Hua Wang
Jian-Hua Wang

1 June 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
GWGuangzhi Wang
Guangzhi Wang
LGLing-Fei Guo
Ling-Fei Guo
GGGui-Hua Gao
Gui-Hua Gao
YLYao Li
Yao Li
XWXi-Zhen Wang
Xi-Zhen Wang
ZYZhen-Guo Yuan
Zhen-Guo Yuan
Purpose: To investigate the diagnostic efficacy of diffusion kurtosis imaging (DKI) and conventional diffusion-weighted imaging (DWI) for pathological grading. Methods: From December 2015 to January 2017, consecutive patients suspected of having hepatocellular carcinoma (HCC) without prior treatment were prospectively enrolled in this study. MRI examinations were performed before surgical treatment. HCC patients confirmed by surgical pathology were included in the study. The mean diffusivity (MD) values, mean kurtosis (MK) values, and apparent diffusion coefficient (ADC) were calculated. The differences and correlations of these parameters among different pathological grades were analyzed. The diagnostic efficiency of DKI and DWI for predicting high-grade HCC was evaluated by receiver operating characteristic (ROC) curves. Logistic regression analyses were used to evaluate the predictive factors for pathological grade. Results: A total of 128 patients (79 males and 49 females, age: 56.9± 10.9 years, range, 32– 80) with primary HCC were included: grade I: 22 (17.2%) patients, grade II: 37 (28.9%) patients, grade III: 43 (33.6%) patients, grade IV: 26 (20.3%) patients. The MK values of stage I, II, III, and IV were 0.86± 0.13, 1.06± 0.11, 1.27± 0.17, and 1.57± 0.13, respectively. The MK values were significantly higher in the high-grade group than in the low-grade group and were positively correlated with pathological grade (rho =0.7417, P< 0.001). The MK value demonstrated a larger area under the curve (AUC), with a value of 0.93 than the MD value, which had an AUC of 0.815 (P< 0.001), and ADC, which had an AUC of 0.662 (P=0.01). The MK value (> 1.19), ADC (≤ 1.29× 10– 3 mm2/s), and HBV (+) were independent predictors for the pathological grade of HCCs. Conclusion: The MK values derived from DKI and the ADC values obtained from traditional DWI were more valuable than the MD values in predicting the histological grade of HCCs and could potentially guide clinical treatment before surgery.

1 November 2013 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
JWJian-Hua Wang
Jian-Hua Wang
ZFZhu-Ting Fang
Zhu-Ting Fang
GWGuangzhi Wang
Guangzhi Wang
WZWei Zhang
Wei Zhang
XQXu-Dong Qu
Xu-Dong Qu
BZBo Zhou
Bo Zhou
Transcatheter arterial embolization (TAE) is widely used as an effective palliative treatment for hepatocellular carcinoma (HCC), and can prolong survival time. However, the high incidence of tumor recurrence and metastasis after TAE is still a major problem. Recent studies demonstrated that circulating tumor cells (CTCs) contribute to tumor metastasis. In this study, we tried to clarify whether the residual HCC after TAE can increase metastasis by increasing the number of CTCs. An orthotopic liver tumor model in the Buffalo rat was established using green fluorescent protein (GFP)-transfected HCC cell line, McA-RH7777. Two weeks after orthotopic liver tumor implantation, the rats underwent TAE treatment from the gastroduodenal artery. Iodized oil or saline was injected intra-arterially. Blood samples were taken on day 0, 1, 3, 7, 14, and 21 for detection of CTCs after TAE treatment. We analyzed the number of CTCs and assessed the metastatic potential of surviving tumor cells in rats between TAE and control groups. Our results demonstrated that the metastatic colonies in the lung were significantly increased by TAE treatment. The number of CTCs was also significantly increased by TAE treatment from day 7 to day 21. The expression of hypoxia-inducible factor (HIF)-1α and epithelial–mesenchymal transition (EMT) marker proteins (N-cadherin and vimentin) was upregulated, but E-cadherin was downregulated after TAE treatment. In conclusion, the metastatic potential of residual HCC can be induced by TAE treatment in a rat liver tumor model, which involves the acquisition of EMT features and an increased number of CTCs.

1 June 2016 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
ZWZeng-Bao Wu
Zeng-Bao Wu
ZSZeng-Mei Si
Zeng-Mei Si
SQSheng Qian
Sheng Qian
LLLing-Xiao Liu
Ling-Xiao Liu
XQXu-Dong Qu
Xu-Dong Qu
JWJian-Hua Wang
Jian-Hua Wang
Background: The purpose of this study was to retrospectively evaluate the therapeutic efficacy and safety of ultrasound-guided percutaneous microwave ablation (MWA) combined with synchronous transcatheter arterial chemoembolization (TACE) in patients with colorectal liver metastases (CRLM). Patients and methods: A retrospective analysis was performed in 30 patients who were treated with ultrasound-guided percutaneous MWA combined with synchronous TACE for colorectal cancer liver metastases from November 2011 to December 2014 in Zhongshan Hospital, Fudan University. The response of the tumor to treatment was evaluated by follow-up computed tomography and/or magnetic resonance imaging. Local tumor control, procedure-related complications, and long-term survival data were analyzed. Results: A total of 30 patients with 43 tumors ranging in size from 1.4 cm to 10.0 cm were analyzed. The patients’ mean age was 61.6±10.3 years (range, 44.0–78.0 years). The median follow-up time was 26.5±10.4 months (range, 13.3–50.6 months). The complete ablation rate was 81.4% (35/43 lesions) for CRLM. Complete response was achieved in eight cases (26.7%), and partial response was achieved in 17 cases (56.7%) 1 month after the procedure. The objective response rate (complete response + partial response) was 83.4%. Progression-free survival and overall survival were 5.0 months and 11.0 months, respectively. The 12-month and 24-month survival rates were 46.7% and 25.4%, respectively. A total of 22 patients succumbed during follow-up due to tumor progression. No major complications or perioperative mortalities were recorded. Conclusion: Ultrasound-guided percutaneous MWA combined with synchronous TACE therapy is a safe and effective modality for patients with CRLM.